CATEGORIES

Healthcare

LATEST

TRENDING

EDITORS CHOICE

The Wearables Expert ™ Interviews Vanessa Carter

Episode 8. João Bocas - The Wearables Expert ™ Interviews Vanessa Carter on Digital Health, Antimicrobial Resistance and Patient Communication

SPRAVATO® (esketamine) CIII Nasal Spray to Treat Depressive Symptoms in Adults Approved

SPRAVATO® (esketamine) CIII nasal spray, taken with an oral antidepressant, to treat depressive symptoms in adults with major depressive disorder (MDD) with acute suicidal ideation or behavior.

Research on Controlling Cellular Outposts of the Immune System

New RNA research. The miR-424(322)/503 gene cluster regulates pro- vs anti-inflammatory skin DC subset differentiation by modulating TGF-beta signaling

AT&T, Samsung and Qure4u Team Up to Deliver Remote Patient Monitoring with FirstNet® for High-Risk Patients

BRADENTON, Fla., Dec. 9, 2021 /PRNewswire/ -- Qure4u, a leader in digital health solutions, is collaborating with AT&T and Samsung to provide remote patient monitoring (RPM) for patients with high blood...